Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Psychiatric Relapse After First-Trimester Antipsychotic Discontinuation in Pregnant Women with Schizophrenia: A Nationwide Cohort Study in South Korea.

Created on 18 Nov 2026

Authors

Jiyeon Kim, Juyeon Lee, Ye-Jee Kim, Sung Woo Joo, Bo Ram Yang

Published in

CNS drugs. Nov 17, 2026. Epub Nov 17, 2026.

Abstract

Antipsychotic discontinuation during the first trimester of pregnancy is common among women with schizophrenia. However, the effect of first-trimester discontinuation on subsequent relapse risk remains limited.
The purpose of this study was to evaluate the association between first-trimester antipsychotic discontinuation and subsequent relapse in pregnant women with schizophrenia.
Using propensity score-based inverse probability of treatment weighting, we compared the risk of psychiatric relapse between women who discontinued treatment in the first trimester and those who continued treatment. Psychiatric relapse was defined as emergency department visits with psychiatric care, psychiatric hospitalizations, or suicide attempts or self-harm occurring from the second trimester through 90 days postpartum. Among women who met the eligibility criteria for schizophrenia, a subgroup analysis was conducted based on the more recent diagnosis of schizophrenia or bipolar disorder recorded within 180 days before pregnancy. A weighted Cox proportional hazards regression model was used to estimate adjusted hazard ratios (aHR) and 95% confidence intervals (CI).
A total of 1205 episodes in the discontinuation group and 585 in the continuation group were included. Compared with the continuation group, first-trimester discontinuation was associated with an increased risk of psychiatric relapse (aHR 2.05, 95% CI 1.47-2.87). Relapse risk was not increased among women whose more recent diagnosis was bipolar disorder (aHR 0.35, 95% CI 0.11-1.10), but was increased among those whose more recent diagnosis was schizophrenia (aHR 2.80, 95% CI 1.93-4.04; p for interaction = 0.01).
First-trimester antipsychotic discontinuation was associated with an increased risk of subsequent psychiatric relapse in women with schizophrenia. Careful clinical monitoring may be warranted when antipsychotic discontinuation is considered during pregnancy.

PMID:
43043401
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement